|Title:||Prostaglanddin derivatives for the treatment of glaucoma or ocular hypertension|
|Abstract:||This invention relates a method for topical treatment of glaucoma or ocular hypertension by administration of an effective intraocular pressure reducing amont of a prostaglandin derivative of PGA, PGB, PGE and PGF, in which the omega chain contains a ring structure. The invention further relates to compositions comprising said prostaglandin derivatives in an ophthalmologically compatible carrier.|
|Inventor(s):||Stjernschantz; Johan W. (Uppsala, SE), Resul; Bahram (Uppsala, SE)|
|Assignee:||Kabi Pharmacia AB (Uppsala, SE)|
|Filing Date:||Feb 25, 1994|
|Claims:||1. A therapeutic composition for topical treatment of ocular hypertension or glaucoma comprising a therapeutically effective amount of the isopropyl ester of 13,14-dihydro-15-dehydro-17-phenyl-18,19,20-trinor-PGF.sub.2.alpha. in a pharmaceutically acceptable carrier. |
2. A method of treating ocular hypertension or glaucoma by topical application of a composition of claim 1.